Table 1.
Baseline demographic and clinical characteristics.
| Patient demographics | 3D-LPN group (n = 69) | LPN group (n = 58) | P value |
|---|---|---|---|
| Age (years), mean (±SD, range) | 48.0 (±11.9, 24–75) | 50.0 (±11.4, 26–70) | >0.05 |
| Sex (male/female), n | 38/31 | 26/32 | >0.05 |
| BMI (kg/m2) mean (±SD, range) | 23.7 (±3.0, 17.7–32.0) | 23.2 (±4.4, 17.8–34.9) | >0.05 |
| ASA status (Grade I/II/III), n | 44/20/5 | 34/21/3 | >0.05 |
| Tumor size (cm), mean (±SD, range) | 4.0 (±2.6, 1.5–11.0) | 3.9 (±1.4, 1.2–6.7) | >0.05 |
| Left/Right, n | 35/34 | 25/33 | >0.05 |
| RENAL score (<8/≥8), n | 33/36 | 39/19 | >0.05 |
| Surgical approach (retro/trans-peritoneal), n | 41/28 | 37/21 | >0.05 |
LPN, laparoscopic partial nephrectomy; SD, standard deviation; BMI, body mass index; ASA, American Society of Anesthesiologists.